| abstract |
The present invention provides a nanoparticle comprising a core comprising a metal and / or semiconductor and a plurality of ligands covalently bonded to the core, wherein the ligand comprises at least one liver targeting ligand, bioactive agent. At least one payload ligand comprising, and at least one diluted ligand comprising a carbohydrate. Also provided are pharmaceutical compositions comprising the nanoparticles, this medical use, including treatment and imaging of liver cancer, and methods for producing the nanoparticles. [Selection figure] None |